![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 43, 40302-40308, October 25, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Metalloenzyme-like Activity of Alzheimer's Disease
-Amyloid
Cu-DEPENDENT CATALYTIC CONVERSION OF DOPAMINE,
CHOLESTEROL, AND BIOLOGICAL REDUCING AGENTS TO NEUROTOXIC
H2O2*
,
,
,
, and
Centro de Regulación
Celular y Patología, Departamento de Biología Celular y
Molecular, Facultad de Ciencias Biológicas, Pontificia
Universidad Católica de Chile, Santiago 114-D, Chile,
§ Laboratory for Oxidation Biology, Genetics and Aging
Research Unit, and Department of Psychiatry, Harvard Medical
School, Massachusetts General Hospital, Charlestown, Massachusetts
02129, ¶ Oxidation Disorders Laboratory, Mental Health
Research Institute of Victoria and Department of Pathology, the
University of Melbourne, Parkville, Victoria 3052, Australia,
Genetics and Aging Research Unit and Department of
Neurology, Harvard Medical School, Massachusetts General Hospital,
Charlestown, Massachusetts 02129, and the ** Haldeman
Laboratory for Alzheimer Disease Research, Sun Health Research
Institute, Sun City, Arizona 85351
-Amyloid (A
) 1-42, implicated
in the pathogenesis of Alzheimer's disease, forms an oligomeric
complex that binds copper at a CuZn superoxide dismutase-like binding
site. A
·Cu complexes generate neurotoxic
H2O2 from O2 through
Cu2+ reduction, but the reaction mechanism has been
unclear. We now report that A
1-42, when binding up to 2 eq of
Cu2+, generates the H2O2
catalytically by recruiting biological reducing agents as substrates
under conditions where the Cu2+ or reducing agents will not
form H2O2 themselves. Cholesterol is an
important substrate for this activity, as are vitamin C, L-DOPA, and dopamine (Vmax
for dopamine = 34.5 nM/min, Km = 8.9 µM). The activity was inhibited by anti-A
antibodies, Cu2+ chelators, and Zn2+. Toxicity
of A
in neuronal culture was consistent with catalytic H2O2 production. A
was not toxic in cell
cultures in the absence of Cu2+, and dopamine (5 µM) markedly exaggerated the neurotoxicity of 200 nM A
1-42·Cu. Therefore, microregional
catalytic H2O2 production, combined with the
exhaustion of reducing agents, may mediate the neurotoxicity of A
in
Alzheimer's disease, and inhibitors of this novel activity may be of
therapeutic value.
*
This work was supported in part by National Health & Medical Research Council, National Institutes of Health Grants
2R01AG12685 (to A. I. B.) and 1K01MH02001 (to X. H.), Prana
Biotechnology Ltd., and Grants Fondo de Investigación Avanzada en
Áreas Prioritarias number 13980001, CIMM-ICA/006 (to N. C. I.)
and Fondo Nacional de Desarrollo Científico y Tecnológico
number 2990087, Dirección de Investigación y Postgrado (to
C. O.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed: Laboratory for
Oxidation Biology, Genetics and Aging Research Unit, Massachusetts General Hospital, Bldg. 114, 16th St., Charlestown, MA 02129. Tel.:
617-726-8244; Fax: 617-724-1823; E-mail:
bush@helix.mgh.harvard.edu.
This article has been cited by other articles:
![]() |
W.-h. Wu, P. Lei, Q. Liu, J. Hu, A. P. Gunn, M.-s. Chen, Y.-f. Rui, X.-y. Su, Z.-p. Xie, Y.-F. Zhao, et al. Sequestration of Copper from {beta}-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents J. Biol. Chem., November 14, 2008; 283(46): 31657 - 31664. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Barnham, V. B. Kenche, G. D. Ciccotosto, D. P. Smith, D. J. Tew, X. Liu, K. Perez, G. A. Cranston, T. J. Johanssen, I. Volitakis, et al. Platinum-based inhibitors of amyloid-{beta} as therapeutic agents for Alzheimer's disease PNAS, May 13, 2008; 105(19): 6813 - 6818. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Weissman, D.-G. Jo, M. M. Sorensen, N. C. de Souza-Pinto, W. R. Markesbery, M. P. Mattson, and V. A. Bohr Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment Nucleic Acids Res., August 17, 2007; (2007) gkm605v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Malm, H. Iivonen, G. Goldsteins, V. Keksa-Goldsteine, T. Ahtoniemi, K. Kanninen, A. Salminen, S. Auriola, T. Van Groen, H. Tanila, et al. Pyrrolidine Dithiocarbamate Activates Akt and Improves Spatial Learning in APP/PS1 Mice without Affecting {beta}-Amyloid Burden J. Neurosci., April 4, 2007; 27(14): 3712 - 3721. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. V. J. Murray, L. Liu, H. Komatsu, K. Uryu, G. Xiao, J. A. Lawson, and P. H. Axelsen Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid beta Proteins J. Biol. Chem., March 30, 2007; 282(13): 9335 - 9345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P Bressler, L. Olivi, J. H. Cheong, Y. Kim, A. Maerten, and D. Bannon Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities Human and Experimental Toxicology, March 1, 2007; 26(3): 221 - 229. [Abstract] [PDF] |
||||
![]() |
C. L. Masters and K. Beyreuther Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A{beta} amyloid pathway Brain, November 1, 2006; 129(11): 2823 - 2839. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Religa, D. Strozyk, R. A. Cherny, I. Volitakis, V. Haroutunian, B. Winblad, J. Naslund, and A. I. Bush Elevated cortical zinc in Alzheimer disease. Neurology, July 11, 2006; 67(1): 69 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Squitti, G. Barbati, L. Rossi, M. Ventriglia, G. Dal Forno, S. Cesaretti, F. Moffa, I. Caridi, E. Cassetta, P. Pasqualetti, et al. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF {beta}-amyloid, and h-tau. Neurology, July 11, 2006; 67(1): 76 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Smith, D. G. Smith, C. C. Curtain, J. F. Boas, J. R. Pilbrow, G. D. Ciccotosto, T.-L. Lau, D. J. Tew, K. Perez, J. D. Wade, et al. Copper-mediated Amyloid-beta Toxicity Is Associated with an Intermolecular Histidine Bridge J. Biol. Chem., June 2, 2006; 281(22): 15145 - 15154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, Q. Liu, Q. Chen, N.-Q. Liu, F.-L. Li, Z.-B. Lu, C. Qin, H. Zhu, Y.-Y. Huang, W. He, et al. Nicotine attenuates {beta}-amyloid-induced neurotoxicity by regulating metal homeostasis FASEB J, June 1, 2006; 20(8): 1212 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Santos, R. A. Quintanilla, A. Toro, R. Grandy, M. C. Dinamarca, J. A. Godoy, and N. C. Inestrosa Peroxisomal Proliferation Protects from {beta}-Amyloid Neurodegeneration J. Biol. Chem., December 9, 2005; 280(49): 41057 - 41068. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Tabner, O. M. A. El-Agnaf, S. Turnbull, M. J. German, K. E. Paleologou, Y. Hayashi, L. J. Cooper, N. J. Fullwood, and D. Allsop Hydrogen Peroxide Is Generated during the Very Early Stages of Aggregation of the Amyloid Peptides Implicated in Alzheimer Disease and Familial British Dementia J. Biol. Chem., October 28, 2005; 280(43): 35789 - 35792. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nguyen, A. Hamby, and S. M. Massa Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model PNAS, August 16, 2005; 102(33): 11840 - 11845. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Z. da Silva, W. M. Tay, and L.-J. Ming Catechol Oxidase-like Oxidation Chemistry of the 1-20 and 1-16 Fragments of Alzheimer's Disease-related {beta}-Amyloid Peptide: THEIR STRUCTURE-ACTIVITY CORRELATION AND THE FATE OF HYDROGEN PEROXIDE J. Biol. Chem., April 29, 2005; 280(17): 16601 - 16609. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Smith, D. D. Norton, M. Gorospe, H. Jiang, S. Nemoto, N. J. Holbrook, T. Finkel, and J. W. Kusiak Phosphorylation of p66Shc and forkhead proteins mediates A{beta} toxicity J. Cell Biol., April 25, 2005; 169(2): 331 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Tickler, D. G. Smith, G. D. Ciccotosto, D. J. Tew, C. C. Curtain, D. Carrington, C. L. Masters, A. I. Bush, R. A. Cherny, R. Cappai, et al. Methylation of the Imidazole Side Chains of the Alzheimer Disease Amyloid-{beta} Peptide Results in Abolition of Superoxide Dismutase-like Structures and Inhibition of Neurotoxicity J. Biol. Chem., April 8, 2005; 280(14): 13355 - 13363. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Quintanilla, F. J. Munoz, M. J. Metcalfe, M. Hitschfeld, G. Olivares, J. A. Godoy, and N. C. Inestrosa Trolox and 17{beta}-Estradiol Protect against Amyloid {beta}-Peptide Neurotoxicity by a Mechanism That Involves Modulation of the Wnt Signaling Pathway J. Biol. Chem., March 25, 2005; 280(12): 11615 - 11625. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Choi, H. D. Rees, S. T. Weintraub, A. I. Levey, L.-S. Chin, and L. Li Oxidative Modifications and Aggregation of Cu,Zn-Superoxide Dismutase Associated with Alzheimer and Parkinson Diseases J. Biol. Chem., March 25, 2005; 280(12): 11648 - 11655. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Nelson and D. L. Alkon Oxidation of Cholesterol by Amyloid Precursor Protein and {beta}-Amyloid Peptide J. Biol. Chem., February 25, 2005; 280(8): 7377 - 7387. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jana and K. Pahan Fibrillar Amyloid-{beta} Peptides Kill Human Primary Neurons via NADPH Oxidase-mediated Activation of Neutral Sphingomyelinase: IMPLICATIONS FOR ALZHEIMER'S DISEASE J. Biol. Chem., December 3, 2004; 279(49): 51451 - 51459. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ghiso, M. Shayo, M. Calero, D. Ng, Y. Tomidokoro, S. Gandy, A. Rostagno, and B. Frangione Systemic Catabolism of Alzheimer's A{beta}40 and A{beta}42 J. Biol. Chem., October 29, 2004; 279(44): 45897 - 45908. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Ciccotosto, D. Tew, C. C. Curtain, D. Smith, D. Carrington, C. L. Masters, A. I. Bush, R. A. Cherny, R. Cappai, and K. J. Barnham Enhanced Toxicity and Cellular Binding of a Modified Amyloid {beta} Peptide with a Methionine to Valine Substitution J. Biol. Chem., October 8, 2004; 279(41): 42528 - 42534. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Bush and D. Strozyk Serum Copper: A Biomarker for Alzheimer Disease? Arch Neurol, May 1, 2004; 61(5): 631 - 632. [Full Text] [PDF] |
||||
![]() |
R. Squitti, E. Cassetta, G. Dal Forno, D. Lupoi, G. Lippolis, F. Pauri, F. Vernieri, A. Cappa, and P. M. Rossini Copper Perturbation in 2 Monozygotic Twins Discordant for Degree of Cognitive Impairment Arch Neurol, May 1, 2004; 61(5): 738 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagano, X. Huang, R. D. Moir, S. M. Payton, R. E. Tanzi, and A. I. Bush Peroxidase Activity of Cyclooxygenase-2 (COX-2) Cross-links {beta}-Amyloid (A{beta}) and Generates A{beta}-COX-2 Hetero-oligomers That Are Increased in Alzheimer's Disease J. Biol. Chem., April 9, 2004; 279(15): 14673 - 14678. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Friedlich, J.-Y. Lee, T. van Groen, R. A. Cherny, I. Volitakis, T. B. Cole, R. D. Palmiter, J.-Y. Koh, and A. I. Bush Neuronal Zinc Exchange with the Blood Vessel Wall Promotes Cerebral Amyloid Angiopathy in an Animal Model of Alzheimer's Disease J. Neurosci., March 31, 2004; 24(13): 3453 - 3459. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Ritchie, A. I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk, L. MacGregor, L. Kiers, R. Cherny, Q.-X. Li, A. Tammer, et al. Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting A{beta} Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial Arch Neurol, December 1, 2003; 60(12): 1685 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Barnham, G. D. Ciccotosto, A. K. Tickler, F. E. Ali, D. G. Smith, N. A. Williamson, Y.-H. Lam, D. Carrington, D. Tew, G. Kocak, et al. Neurotoxic, Redox-competent Alzheimer's {beta}-Amyloid Is Released from Lipid Membrane by Methionine Oxidation J. Biol. Chem., October 31, 2003; 278(44): 42959 - 42965. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bahadi, P. V. Farrelly, B. L. Kenna, C. C. Curtain, C. L. Masters, R. Cappai, K. J. Barnham, and J. I. Kourie Cu2+-induced modification of the kinetics of A{beta}(1-42) channels Am J Physiol Cell Physiol, October 1, 2003; 285(4): C873 - C880. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Bush, C. L. Masters, and R. E. Tanzi Copper, {beta}-amyloid, and Alzheimer's disease: Tapping a sensitive connection PNAS, September 30, 2003; 100(20): 11193 - 11194. [Full Text] [PDF] |
||||
![]() |
K. J. Barnham, W. J. McKinstry, G. Multhaup, D. Galatis, C. J. Morton, C. C. Curtain, N. A. Williamson, A. R. White, M. G. Hinds, R. S. Norton, et al. Structure of the Alzheimer's Disease Amyloid Precursor Protein Copper Binding Domain. A REGULATOR OF NEURONAL COPPER HOMEOSTASIS J. Biol. Chem., May 2, 2003; 278(19): 17401 - 17407. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |